Scabies Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Infectopharm Arzneimittel GmbH, Mylan Laboratories, Saptalis Pharmaceuticals

June 06 20:25 2023
Scabies Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Infectopharm Arzneimittel GmbH, Mylan Laboratories, Saptalis Pharmaceuticals
DelveInsight’s “Scabies Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Scabies.

DelveInsight’s “Scabies Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Scabies, historical and forecasted epidemiology as well as the Scabies market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Scabies market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Scabies Market Forecast

 

Some of the key facts of the Scabies Market Report: 

  • The Scabies market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The predicted global prevalence is 200 million persons, with significant regional heterogeneity in prevalence, according to Goldstein et al. (2022)
  • Population-based research from several regions, excluding North America, by Goldstein et al. (2022), indicate that the estimated prevalence ranges from 0.2 to 71%, with the Asia Pacific area and Latin America having the highest prevalence
  • Key Scabies Companies: Medicines development for global health, Infectopharm Arzneimittel GmbH, Mylan Laboratories, Saptalis Pharmaceuticals, bioRASI, LLC, ParaPRO LLC, and others
  • Key Scabies Therapies: Moxidectin, Permethrin Foam 4%, InfectoScab, Permethrin Cream, Elimite, Spinosad, and others
  • The Scabies epidemiology based on  gender analyzed that females are more prevalent for scabies as compared to males. It has been found that 39.2% females and 33.7% male are affected by scabies
  • The Scabies market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Scabies pipeline products will significantly revolutionize the Scabies market dynamics.

 

Get a Free sample for the Scabies Market Report 

https://www.delveinsight.com/report-store/scabies-market

 

Scabies Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Scabies Epidemiology Segmentation:

The Scabies market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Scabies
  • Prevalent Cases of Scabies by severity
  • Gender-specific Prevalence of Scabies
  • Diagnosed Cases of Episodic and Chronic Scabies

 

Download the report to understand which factors are driving Scabies epidemiology trends @ Scabies Epidemiology Forecast

 

Scabies Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Scabies market or expected to get launched during the study period. The analysis covers Scabies market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Scabies Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Scabies Therapies and Key Companies

  • Moxidectin: Medicines development for global health
  • InfectoScab 5% cream: Infectopharm Arzneimittel GmbH
  • Permethrin Foam 4%: Mylan Laboratories
  • InfectoScab: Infectopharm Arzneimittel
  • Permethrin Cream: Saptalis Pharmaceuticals
  • Elimite: bioRASI, LLC
  • Spinosad: ParaPRO LLC

 

Discover more about therapies set to grab major Scabies market share @ Scabies Treatment Market

 

Scope of the Scabies Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Scabies Companies: Medicines development for global health, Infectopharm Arzneimittel GmbH, Mylan Laboratories, Saptalis Pharmaceuticals, bioRASI, LLC, ParaPRO LLC, and others
  • Key Scabies Therapies: Moxidectin, Permethrin Foam 4%, InfectoScab, Permethrin Cream, Elimite, Spinosad, and others
  • Scabies Therapeutic Assessment: Scabies current marketed and Scabies emerging therapies
  • Scabies Market Dynamics: Scabies market drivers and Scabies market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Scabies Unmet Needs, KOL’s views, Analyst’s views, Scabies Market Access and Reimbursement 

 

To know more about Scabies companies working in the treatment market, visit @ Scabies Clinical Trials and Therapeutic Assessment

 

Table of Content

1. Scabies Market Report Introduction

2. Executive Summary for Scabies

3. SWOT analysis of Scabies

4. Scabies Patient Share (%) Overview at a Glance

5. Scabies Market Overview at a Glance

6. Scabies Disease Background and Overview

7. Scabies Epidemiology and Patient Population

8. Country-Specific Patient Population of Scabies 

9. Scabies Current Treatment and Medical Practices

10. Scabies Unmet Needs

11. Scabies Emerging Therapies

12. Scabies Market Outlook

13. Country-Wise Scabies Market Analysis (2019–2032)

14. Scabies Market Access and Reimbursement of Therapies

15. Scabies Market Drivers

16. Scabies Market Barriers

17.  Scabies Appendix

18. Scabies Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

  Categories: